Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer

Conclusion: Although preoperative cisplatin/paclitaxel with 3,000 cGy was tolerable, this multimodality regimen did not appear to be superior to standard cisplatin/5-fluorouracil-containing regimens and its use is not recommended.